We use cookies to deliver our online services. Details of the cookies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you agree to our use of cookies. To close this message click close.

2019 White House and HHS budgets released: Key changes to drug pricing and reimbursement proposed

15 February 2018

Health Alert

On February 12, 2018, the White House Office of Management and Budget released an overview of the president's Fiscal Year (FY) 2019 Budget (the Budget), which makes, among many others, several proposals regarding drug pricing and payment reform. Concurrently, the Department of Health and Human Services (HHS) released the full FY 2019 Budget for HHS (the HHS Budget), which provides additional detail regarding such proposals.

In presenting these proposals, the administration is seeking Congressional action; thus, the fate of these proposals is highly uncertain. Nevertheless, these proposals provide insight into the administration's – and particularly the new HHS Secretary Alex Azar's – thinking with respect to how the administration might go about fulfilling its frequent but often non-specific promise to precipitate such reform.

Read More: 2019 White House and HHS Budgets Released: Key Changes to Drug Pricing and Reimbursement Proposed


Loading data